Cullinan Therapeutics, Inc. (CGEM)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$17.32
-0.84%
Mkt Cap $1.06B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (16 analysts)
$31.25
Range $28.00 – $37.00
Implied Upside
+80.4%
Consensus $31.25 vs current $17.32